A similar work demonstrated the anti-tumor role of Dll4 blockade in breast cancer mouse xenograft models, where combined treatment of anti-Dll4 antibody in combination with docetaxel led to tumor cell apoptosis, CSC phenotype and reversal of EMT (Xu Z. et al., 2016). This evidence concerns the gene DLL4 and breast carcinoma.